Dengue Literature Review

Dengue Pathophysiology

17 min read

Dengue Pathophysiology

Overview

Dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) are defined by three interacting pathological phenomena: (1) increased vascular permeability causing plasma leakage, (2) thrombocytopaenia with impaired platelet function, and (3) coagulopathy with altered haemostasis. These occur in a coordinated, time-locked pattern — emerging during the febrile phase, peaking at defervescence, and typically resolving within 24–36 hours in non-fatal cases. Understanding the molecular drivers of each phenomenon is essential to developing targeted therapies, vaccines, and prognostic tools.

Key Points from Literature

Vascular Permeability

  • The cardinal feature of DHF/DSS; defined by plasma leakage into serous cavities (pleural effusion, ascites) and into the interstitial space
  • Endothelial cell death and direct viral infection of endothelium do not appear to be the primary mechanism: patients recovering from DHF regain normal endothelial function rapidly, implying a reversible soluble mediator rather than structural damage (see Guzman2016 - Dengue Infection)
  • Onset at defervescence, not during peak viraemia — suggesting vascular permeability results from factors that accumulate throughout the febrile phase and surpass a threshold at fever resolution
  • NS1 as a direct trigger: sNS1 activates TLR4 on myeloid cells → pro-inflammatory cytokines; separately, sNS1 disrupts endothelial monolayer integrity in vitro and in vivo; DENV NS1-induced TLR4 signalling is a proposed central mechanism for barrier dysfunction (see Guzman2016 - Dengue Infection, NS1 Protein)
  • APTT as strongest vascular permeability correlate: APTT values (measuring coagulation activation time) are the strongest laboratory correlate of vascular permeability in dengue patients — linking coagulopathy and plasma leakage mechanistically (see Guzman2016 - Dengue Infection)
  • Anti-NS1 autoantibodies additionally induce endothelial apoptosis (NO→p53/Bax/caspase-3 pathway) and NF-κB inflammatory activation (IL-6, IL-8, MCP-1; ICAM-1 upregulation) — a distinct antibody-mediated vascular damage pathway (see NS1 Molecular Mimicry in Dengue)
  • Anti-PDI, anti-HSP60, and anti-vimentin IgM/IgG are elevated in DHF vs. controls; anti-PDI antibodies generated via NS1 P311–330 molecular mimicry may additionally disrupt PDI-mediated integrin activation on the endothelial surface — providing a mechanistic link between NS1 mimicry and endothelial barrier dysfunction (see Cheng2015 - NS1 P311-330 Anti-PDI Autoantibodies in DHF, NS1 Molecular Mimicry in Dengue)

Thrombocytopaenia

  • Two concurrent mechanisms:
    1. Bone marrow suppression: early febrile phase; suppression of all blood cell lineages; proposed to be mediated by IFN-β (by analogy with lymphocytic choriomeningitis virus in animal models); megakaryocyte arrest persists until near the end of the febrile period
    2. Peripheral platelet destruction: immune-mediated; mechanism depends on infection order:
  • Platelet counts can fall to 5,000/ml (normal ~200,000/ml) at nadir
  • Thrombocytopaenia is common across infectious diseases generally; it is the combination of thrombocytopaenia with vascular permeability that is distinctive of DHF/DSS
  • Platelet count is NOT a reliable predictor of bleeding severity in dengue; risk factors for severe haemorrhage are duration of shock and low-to-normal haematocrit at shock onset (see Guzman2016 - Dengue Infection) (see also Guzman2016 - Dengue Infection)

Glycocalyx Degradation — Cathepsin L and Heparanase Pathways (Bhatt2020)

Bhatt2020 - Dengue Pathogenesis Review adds two specific enzymatic mechanisms for NS1-driven glycocalyx degradation that complement the Guzman2016 description of glycocalyx shedding:

  • Heparanase activation: NS1 activates endothelial heparanase (endo-β-glucuronidase), which cleaves heparan sulfate chains within the glycocalyx — removing the core anticoagulant/antiadhesive surface layer and releasing heparan sulfate fragments into circulation
  • Cathepsin L activation: NS1 also activates cathepsin L (a lysosomal cysteine protease), which degrades the protein core of heparan sulfate proteoglycans — providing a parallel structural route to glycocalyx loss that is independent of heparanase

Together, these mechanisms offer two enzymatic routes to glycocalyx depletion: enzymatic cleavage of the sugar chains (heparanase) and proteolytic cleavage of the protein cores (cathepsin L). The downstream consequences are: (1) increased vascular permeability from loss of the endothelial surface barrier; (2) release of anticoagulant heparan sulfate into the bloodstream contributing to the coagulopathic picture; (3) exposure of integrin binding sites facilitating platelet-endothelial adhesion.

This fills a mechanistic gap in the existing glycocalyx-shedding model: Guzman2016 established that glycocalyx loss occurs in dengue but did not specify the enzymatic mediators beyond NS1’s general disruptive role on the endothelial barrier.

Coagulopathy

  • Characterised by prolonged APTT (activated partial thromboplastin time), reduced fibrinogen, and reduced anticoagulant protein concentrations
  • Classic disseminated intravascular coagulation (DIC) is debated: procoagulant marker elevation is present but usually mild; anticoagulant protein reduction is more prominent
  • NS1-thrombin binding: sNS1 binds thrombin in vivo forming NS1-thrombin complexes; rNS1 inhibits prothrombin activation and prolongs APTT in human platelet-deficient plasma (see Guzman2016 - Dengue Infection)
  • E protein WGNGCG motif: E protein aa 101–106 homologous to coagulation factors (XI, X, IX, VII, thrombin, plasminogen, tPA); anti-E antibodies inhibit plasmin activity (see NS1 Molecular Mimicry in Dengue, E Protein)
  • Glycocalyx shedding: NS1 may shed heparan sulfate/chondroitin sulfate from the endothelial glycocalyx → anticoagulant molecules enter circulation → contributes to coagulopathy (see Guzman2016 - Dengue Infection)
  • Most coagulopathy is minor and self-limiting; major haemorrhage is usually a complication of prolonged shock, not a primary dengue effect
  • The APTT-vascular permeability correlation raises the possibility that coagulation interference is proximal to, not merely co-incident with, plasma leakage

Auto-Antibody-Mediated Profibrinolysis and Hyperfibrinolysis

Beyond direct NS1 coagulation effects, cross-reactive auto-antibodies generated via molecular mimicry between DENV proteins and fibrinolytic factors produce a distinct dual fibrinolysis mechanism (see Coagulation and Fibrinolysis in Dengue, Ghorai2024 - Autoantibodies in Dengue Pathogenesis Review — secondary review citing Chuang 2013/2014):

  • Profibrinolysis: auto-antibodies bind plasminogen → act on fibrinogen → regulated breakdown of fibrinogen; contributes to hypocoagulability
  • Hyperfibrinolysis: auto-antibodies bind the plasminogen complex → excessive production of fibrin degradation products (FDP) → increased bleeding risk; the clinical laboratory signature is decreased fibrinogen AND elevated FDP/D-dimer in DHF/DSS
  • scFv from NS1-immunised mice cross-react with fibrinogen and prolong thrombin time in vitro — confirming NS1 can generate auto-antibodies capable of coagulation interference at the fibrin formation step (Chuang 2014, cited in Ghorai2024)
  • Multiple studies have documented correlation between anti-plasminogen antibodies and haemorrhage in DENV patients (Markoff 1991 — first report; Warter 2012)

Caveat: The scFv experiments used engineered monoclonal fragments. Whether natural polyclonal anti-plasminogen/anti-fibrinogen auto-antibodies in dengue patient sera achieve sufficient concentration for these effects is not established from cohort data. The relative contribution of this mechanism vs. direct NS1-thrombin binding remains unquantified.

Cytotoxic Factor (hCF) and Anti-hCF Autoantibodies — Chaturvedi2001 (⚠ unvalidated concept)

Chaturvedi2001 - Cytotoxic Factor Autoantibodies DHF proposes an additional mechanism for vascular permeability: a dengue-specific cytokine (hCF) produced by CD4+ T cells induces macrophage free-radical and pro-inflammatory cytokine production, and shifts the immune response from Th1 to Th2 (see Cytotoxic Factor in Dengue). hCF levels were highest in DHF grade IV patients and lowest in mild DF patients in the 1996 North India epidemic cohort (n=136). The reverse pattern was observed for host-produced anti-hCF autoantibodies, which were present in 96% of DF patients and only 8% of DHF grade IV patients — a finding the authors interpret as evidence that anti-hCF autoantibodies protect against severe disease by neutralising hCF before it can drive the full pathogenic cascade.

Caveat: hCF is the Chaturvedi group’s own concept with no independent replication. The relationship of this mechanism to the established NS1-TLR4, ADE, and OAS pathways is unclear — it may represent an upstream driver, a parallel pathway, or a recharacterisation of known mechanisms.

In Vivo Endothelial Structural Damage — Thrombomodulin as Biomarker

Hung2008 - Anti-Platelet Anti-Endothelial Autoantibodies Vietnam provides direct in vivo evidence that endothelial structural damage — not merely functional permeability change — occurs in DHF/DSS. Serum thrombomodulin (TM), an integral membrane glycoprotein released from damaged endothelial cells, was measured in Vietnamese paediatric DHF/DSS patients:

  • Infants: TM 6.1 ± 1.7 pg/mL vs controls 2.7 ± 0.4 pg/mL (p<0.001)
  • Children: TM 8.8 ± 2.1 pg/mL vs controls 2.4 ± 0.06 pg/mL (p=0.01)
  • TM was not significantly different between non-shock DHF and DSS in either group (p=0.2 and p=0.4), indicating endothelial damage is present across the DHF severity spectrum
  • TM was not correlated with anti-EC autoantibody levels or with haematocrit increase (plasma leakage), suggesting that autoantibody-mediated endothelial damage and functional plasma leakage are partially dissociated mechanisms

This is an important mechanistic distinction: the standard dengue vascular leakage model proposed that plasma leakage was due to functional (transient, cytokine-mediated) rather than structural (cell death-driven) endothelial barrier disruption, based on the rapid reversibility of plasma leakage after fluid resuscitation. The TM elevation suggests that actual endothelial structural injury does occur in DHF/DSS — both models may apply in parallel. The lack of TM-severity correlation suggests the injury threshold is crossed even in non-shock DHF, and additional factors (volume of leakage, rapidity, fluid management) determine whether shock supervenes.

Cryoglobulinemia and Serositis in DHF

Jardim2012 - Autoimmune Features DHF Case Report (n=1 case report, Brazil — not generalizable) documents cryoglobulinemia (cold-precipitating immunoglobulins, likely mixed type II/III immune complexes) alongside triple serositis (pleural, pericardial, ascitic) in secondary DENV-3 DHF. This is the only cryoglobulinemia case in this wiki associated with dengue. The cryoglobulinemia is mechanistically coherent with dengue’s known circulating immune complex (IC) generation in secondary infection: the same IC pool driving PAIgG/PAIgM platelet loading (see Saito2004 - PAIgG and PAIgM in Secondary Dengue, Oishi2003 - PAIgG and Thrombocytopenia in Secondary Dengue) may precipitate as cryoglobulins in susceptible individuals. The patient also showed selective C3 depression (0.39 g/L) with C4 within normal range — contrasting with the classical pathway complement pattern (both C3 and C4 depleted) seen in Rajadhyaksha2012 - Dengue Evolving into SLE and Lupus Nephritis, suggesting alternative or MBL pathway complement activation, or early-phase disease before C4 consumption.

LE cells were documented in pleural fluid cytology — requiring anti-nuclear IgG, complement activation, and nuclear material release, consistent with the complement and immune complex features of this case.

Immune Complex-Mediated Renal Pathology

Dengue viremia can trigger excessive antibody production; in susceptible individuals the resulting viral antigen–antibody immune complexes may deposit in the kidney causing renal tubular damage and glomerulonephritis (see Rajadhyaksha2012 - Dengue Evolving into SLE and Lupus Nephritis, n=1 case report — not generalizable). In this single case, primary DENV-1 infection was followed 4 weeks later by Class IV diffuse proliferative glomerulonephritis with ANA 1:320, anti-dsDNA 1:80, and severe hypocomplementemia (C3 22 mg/dL), consistent with lupus nephritis triggered by or unmasked by dengue. Whether dengue viral ICs or anti-nuclear ICs drove the GN was not determined by the biopsy immunofluorescence. Dengue-associated acute kidney injury more broadly includes hypotension, rhabdomyolysis, and sepsis as additional mechanisms beyond immune complex deposition.

Complement Activation

  • Complement system activated to control DENV infection but its activation contributes to pathogenesis
  • Secondary infection: classical complement pathway activation via circulating immune complexes; levels of C3a/C5a elevated; temporal correlation with fibrinogen and thrombocytopaenia changes
  • Primary infant infection: alternative complement pathway activated; NS1 may directly activate complement by the alternative pathway
  • Activated complement interacts with the coagulation system, amplifying both coagulopathy and vascular inflammation (see Guzman2016 - Dengue Infection)
  • NS1 → C5b-C9 → NLRP3 inflammasome: Soluble DENV NS1 independently activates fluid-phase complement factors; a close correlation has been reported between NS1 concentration and C5b-C9 complex formation (Kurosu 2007, as cited in Pang2017 - DHF Pathogenesis Review). C5b-C9 (the membrane attack complex) then stimulates robust expression of inflammatory cytokines via NLRP3 inflammasome activation (Suresh 2016, as cited in Pang2017 - DHF Pathogenesis Review). This provides a mechanistic link between NS1 antigenaemia, terminal complement pathway activation, and cytokine-driven DHF pathogenesis. Note: Suresh 2016 is a general complement biology paper; direct confirmation in dengue patient samples has not yet been published in this wiki’s sources.

Autoantibodies Against Complement and Coagulation Components

A protein microarray screen in Cambodian pediatric dengue patients revealed that IgG autoantibodies against complement components and coagulation proteins are produced during DENV infection and correlate with platelet counts in DHF (see Vo2020 - Autoantibody Profiling in Dengue):

  • IgM autoantibodies against complement proteins C5, C8, C9, Factor B, Factor H, and Factor P were elevated in DENV-infected patients vs. healthy donors
  • In DHF patients specifically, low levels of anti-Factor P IgG and anti-complement C4 IgG correlated with low platelet counts (both p < 0.05), as did anti-prothrombin IgG
  • The correlation is positive (higher Ab = higher platelets), implying these autoantibodies are consumed through immune complex formation as DHF worsens, rather than being directly pathogenic
  • Factor P (properdin) stabilises the alternative C3 convertase (C3bBb); Factor H inhibits it. Prior reports showed DHF patients have lower Factor H expression, promoting the alternative complement cascade. The Vo2020 data adds that IgG against both proteins is depleted in severe disease — consistent with immune complex formation sequestering these proteins and further imbalancing the complement system toward activation
  • Anti-heparan-sulfate and anti-proteoglycan IgG autoantibodies were decreased in DF/DHF vs. asymptomatic patients, raising the speculative hypothesis that anti-heparan sulfate Abs may block DENV attachment to cell membranes (heparan sulfate proteoglycans are a putative DENV receptor) and that their depletion could facilitate infection

Liver Involvement

  • Hepatomegaly in 55% of DHF cases vs. 18% of DF cases (P<0.01); significantly more common in severe disease
  • Mechanisms: (1) generalised oedema from vascular permeability; (2) inflammatory response to hepatocyte infection by DENVs
  • Histopathology: Councilman bodies (apoptotic DENV-infected hepatocytes engulfed by Kupffer cells) — the same histological finding as in yellow fever (another flavivirus); almost no cellular inflammatory infiltrate in fatal cases, suggesting apoptosis rather than inflammatory hepatocyte death
  • AST/ALT elevated in 60–90% of children with DHF; 7–10% have levels >10× upper limit of normal
  • Jaundice is rare despite hepatomegaly; gamma-glutamyl transpeptidase elevated in 83% of cases
  • Post-dengue liver enzyme elevation may persist for months; anti-NS1 hepatitis-like effects in mouse models (see Lin2006 - Autoimmune Pathogenesis in Dengue Virus Infection) (see Guzman2016 - Dengue Infection)

Contradictions & Debates

  • Cause of vascular permeability: Multiple competing models exist — NS1-TLR4, cytokine storm (T cell-mediated), immune complex complement activation, anti-NS1 autoantibody endothelial damage — none fully accounts for all observations. The paper itself notes that none of the existing explanations can account for why infants with no prior infection develop severe dengue.
  • DIC vs non-DIC: The haemostatic profile of DHF resembles but does not fully meet diagnostic criteria for classic DIC; some researchers distinguish dengue coagulopathy as mechanistically distinct.
  • NS1 as mediator vs. marker: sNS1 levels correlate with severity, NS1 can cause endothelial disruption in vitro, and NS1-thrombin binding has been demonstrated in vivo — but whether NS1 is the primary driver of vascular permeability or a secondary marker of disease severity remains debated.

Acute Abdomen and Gastrointestinal Manifestations (Farias2024)

Farias2024 - Dengue Mimickers (narrative review, Brazil) documents the gastrointestinal/abdominal presentations of dengue as a source of diagnostic confusion:

  • Acute abdomen incidence: ~12% in one Pakistan series; presentations mimic acute cholecystitis, appendicitis, pancreatitis, and splenic rupture — leading to unnecessary surgery with high haemorrhagic risk (thrombocytopenic dengue patients who undergo surgery need transfusions and have extended hospitalisations)
  • Two hypotheses for dengue pancreatitis: (1) autoimmune response to pancreatic islet cells; (2) direct viral invasion and destruction of pancreatic acinar cells
  • Gallbladder wall thickening (GBWT) >3mm as DHF ultrasound marker:
    • Study of 21 typical DEN + 111 DHF: GBWT >3mm useful for confirming suspected DHF
    • Study of 44 patients with severe DEN: 90.5% sensitivity / 69.6% specificity; GBWT 100% sensitivity for determining ICU vs. general ward (specificity 62.1%)
    • Study of 160 suspected DEN: 58% sensitivity / 84% specificity — lower sensitivity cautions against using ultrasound as a screening tool
    • Ultrasound showing GBWT + pleural effusion + ascites + hepatomegaly + splenomegaly strongly suggests DHF in clinically suspected cases; cannot rule out dengue when negative
  • DEN warning signs before surgery: Careful history, dengue antigen testing, and serial blood counts should be performed before surgical intervention in endemic regions — dengue presenting as acute abdomen should be managed conservatively when uncomplicated

Sources

  • Guzman2016 - Dengue Infection
  • Lin2006 - Autoimmune Pathogenesis in Dengue Virus Infection (anti-NS1 hepatitis-like effects in mouse models)
  • Lin2001 - IgM Anti-Platelet Autoantibody in Dengue Patients (primary-infection platelet pathology: anti-platelet IgM, complement-mediated lysis severity-correlated, aggregation inhibition not; NS1-platelet cross-reactivity as mechanistic origin)
  • Morel2014 - Autoimmune Response in Children With Dengue (MAS/HLH as severe dengue immunopathology; hyperferritinemia, triglyceridemia, organomegaly; macrophage hyperactivation as distinct pathophysiological axis from autoantibody-mediated mechanisms)
  • Oishi2003 - PAIgG and Thrombocytopenia in Secondary Dengue (secondary-infection thrombocytopenia mechanism: PAIgG–platelet count inverse correlation r=−0.570; immune complex macrophage/complement platelet clearance; FcγRII-independent dengue-platelet binding)
  • Saito2004 - PAIgG and PAIgM in Secondary Dengue (PAIgM extension: both isotypes inversely correlated with platelet count; anti-dengue IgM confirmed in platelet eluates; PAIgM >20 ng/10⁷ predicts DHF with 92.1% specificity; FcγR bypass for PAIgM via IgM pentamer structure)
  • Vo2020 - Autoantibody Profiling in Dengue (protein microarray; IgM autoantibodies against complement C5, C8, C9, Factor B, H, P elevated vs. HD; anti-Factor P IgG + anti-C4 IgG + anti-prothrombin IgG positively correlated with platelet counts in DHF [consumption model]; anti-heparan sulfate/proteoglycan IgG decreased in DF/DHF vs. ASD; Cambodia pediatric cohort)
  • Bhatt2020 - Dengue Pathogenesis Review (glycocalyx degradation: NS1 activates heparanase → heparan sulfate chain cleavage; NS1 activates cathepsin L → proteoglycan core cleavage; dual enzymatic glycocalyx loss mechanism; MIF-autophagy viral amplification; review, India)
  • Pang2017 - DHF Pathogenesis Review (NS1 → fluid-phase complement activation → C5b-C9 complex → NLRP3 inflammasome → DHF-associated cytokines; ADE risk quantification: secondary infection DHF 118–208/1000 vs. 11–12/1000 primary; review, China)
  • Rajadhyaksha2012 - Dengue Evolving into SLE and Lupus Nephritis (immune complex-mediated renal pathology: primary DENV-1 → severe hypocomplementemia [C3 22 mg/dL, C4 5 mg/dL] + Class IV GN 4 weeks post-dengue; mechanism: dengue viral IC deposition proposed; Mumbai India; n=1 case report — not generalizable)
  • Jardim2012 - Autoimmune Features DHF Case Report (secondary DENV-3 DHF; cryoglobulinemia [first in wiki]; triple serositis; selective C3 depression with C4-normal; LE cells in pleural fluid; DIC with fibrinogen 85.5 mg%; all resolved at follow-up; Campinas Brazil; n=1 case report — not generalizable)
  • Chaturvedi2001 - Cytotoxic Factor Autoantibodies DHF (hCF → macrophage free radicals + IL-1α/TNF-α/IL-8/peroxynitrite cascade → vascular permeability; anti-hCF autoantibodies inversely correlated with DHF severity [96% DF → 8% DHF-IV]; reverse correlation with hCF titres; 1997 WHO DHF grades I–IV; n=136, 1996 North India epidemic; ⚠ group-specific concept)
  • Cheng2015 - NS1 P311-330 Anti-PDI Autoantibodies in DHF (anti-PDI/HSP60/vimentin IgM/IgG elevated in DHF vs. controls; anti-PDI IgM correlated with anti-EC IgM [r = 0.649, P < 0.0001]; P311–330 as PDI-specific NS1 epitope; anti-PDI may disrupt PDI-mediated integrin activation → endothelial barrier dysfunction; primary/secondary infection independence of anti-endothelial autoantibodies; NCKU Tainan; n=15 DHF + 2 DF, Vietnamese paediatric cohort)
  • Farias2024 - Dengue Mimickers (acute abdomen ~12% of DEN cases; GBWT >3mm as DHF ultrasound marker [sensitivity 58–90.5% across studies]; dengue pancreatitis mechanisms; surgery risks in thrombocytopenic dengue; Brazil narrative review — secondary source)
  • Hung2008 - Anti-Platelet Anti-Endothelial Autoantibodies Vietnam (thrombomodulin elevated in infants [6.1 vs 2.7 pg/mL, p<0.001] and children [8.8 vs 2.4 pg/mL, p=0.01] — in vivo endothelial structural damage confirmed; anti-EC autoantibodies not correlated with haematocrit increase; anti-platelet IgM in infants with primary dengue; HCMC Vietnam paediatric cohort)
  • Ghorai2024 - Autoantibodies in Dengue Pathogenesis Review (profibrinolysis and hyperfibrinolysis dual mechanism via anti-plasminogen auto-antibodies; anti-NS1 AECA hepatic inflammation: Lin 2008 murine model with fatty liver, necrotic body, liver fibrosis, mononuclear phagocytic cell infiltration; DHF coagulopathy markers; complement alternative pathway C3bBb formation in DHF; Kolkata India review — secondary source)

Graph View

Backlinks